Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nadolol Versus Propranolol in Children With Infantile Hemangiomas: a Randomized, Controlled, Double-blinded Trial

NCT02505971 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02505971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nadolol Versus Propranolol in Children With Infantile Hemangiomas: a Randomized, Controlled, Double-blinded Trial
Lead sponsor
The Hospital for Sick Children
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2020
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma